WithdrawnNot Applicable

Mild Hip Dysplasia

Stopped: No enrollment

0Started 2018-06-01

Plain-language summary

Hip dysplasia is a complex problem that exists on a spectrum from mild to severe disease. Periacetabular osteotomy (PAO) remains the gold standard for most patients with dysplasia; however, the procedure is quite invasive making the decision to proceed in cases of mild disease difficult. Hip arthroscopy (HA) is an alternative minimally invasive technique that can be used to address mild dysplasia. Nevertheless, HA has less capability for correction and in rare instances can exacerbate instability in the dysplastic hip. There is a paucity of data examining outcomes between these two treatment strategies for this challenging problem.

Who can participate

Age range18 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of symptomatic mild DDH * Lateral center-edge angle 18° - 25° and/or Tӧnnis angle 8° - 15° * Skeletally mature * Age 18 - 45 * Tonnis Grade 0 or 1 osteoarthritis (minimal or no arthritis) * Ability to receive a standard of care preoperative MRI arthrogram of the hip Exclusion Criteria: * Pregnant women * Neurogenic dysplasia * Legg-Calvé-Perthes disease * Previous surgery about the hip including previous hip arthroscopy to address intra-articular pathology

What they're measuring

The Forgotten Joint Score-12 (FJS-12)

Timeframe: 1 year

Trial details

NCT IDNCT03530878

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-01-11

View on ClinicalTrials.gov More Hip Dysplasia trials